Chiron, Biometric Imaging sign agreement to research microvolume fluorimetry for cell analysis.
This article was originally published in The Gray Sheet
Executive Summary
CHIRON, BIOMETRIC IMAGING COLLABORATIVE AGREEMENT IN CELL ANALYSIS could expand use of Biometric Imaging's microvolume fluorimetry technology into the areas of oncology and infectious disease. The companies announced Nov. 6 an agreement to "explore the use" of Biometric Imaging's technology for cellular analysis. Under the deal, Chiron has taken an undisclosed minority equity stake in Mountain View, California-based Biometric Imaging.